These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 1556844

  • 1. [Treatment of rejection with deoxyspergualin after renal transplantation].
    Shinohara Y, Imanishi M, Nishioka T, Uemura T, Kanda H, Matsuura T, Akiyama T, Kurita T.
    Nihon Hinyokika Gakkai Zasshi; 1992 Feb; 83(2):236-42. PubMed ID: 1556844
    [Abstract] [Full Text] [Related]

  • 2. [The experience of administration of 15-deoxyspergualin on rejection in kidney transplant recipients].
    Takano Y, Takahara S, Kokado Y, Kameoka H, Ishibashi M, Jiang H, Okuyama A, Sonoda T.
    Nihon Hinyokika Gakkai Zasshi; 1992 Feb; 83(2):230-5. PubMed ID: 1556843
    [Abstract] [Full Text] [Related]

  • 3. A novel rescue drug, 15-deoxyspergualin. First clinical trials for recurrent graft rejection in renal recipients.
    Amemiya H, Suzuki S, Ota K, Takahashi K, Sonoda T, Ishibashi M, Omoto R, Koyama I, Dohi K, Fukuda Y.
    Transplantation; 1990 Feb; 49(2):337-43. PubMed ID: 2407004
    [Abstract] [Full Text] [Related]

  • 4. Deoxyspergualin: clinical trials in renal graft rejection. Japan Collaborative Transplant Study of Deoxyspergualin.
    Amemiya H.
    Ann N Y Acad Sci; 1993 Jun 23; 685():196-201. PubMed ID: 8363223
    [Abstract] [Full Text] [Related]

  • 5. Pilot evaluation of 15-deoxyspergualin for refractory acute renal transplant rejection.
    Matas AJ, Gores PF, Kelley SL, Bielefield-Skrokov M, Kinaszczuk M, Gruessner RW, Najarian JS.
    Clin Transplant; 1994 Apr 23; 8(2 Pt 1):116-9. PubMed ID: 8019020
    [Abstract] [Full Text] [Related]

  • 6. 15-Deoxyspergualin: a newly developed immunosuppressive agent and its mechanism of action and clinical effect: a review. Japan Collaborative Transplant Study Group for NKT-01.
    Amemiya H.
    Artif Organs; 1996 Aug 23; 20(8):832-5. PubMed ID: 8853792
    [Abstract] [Full Text] [Related]

  • 7. Effect of deoxyspergualin on vascular rejection in canine kidney transplantation.
    Tanabe K, Takahashi K, Nemoto K, Okada M, Yasuo M, Hayasaka Y, Toma H, Ota K.
    J Urol; 1994 Aug 23; 152(2 Pt 1):562-6. PubMed ID: 8015112
    [Abstract] [Full Text] [Related]

  • 8. Multicentre clinical trial of antirejection pulse therapy with deoxyspergualin in kidney transplant patients.
    Amemiya H, Suzuki S, Ota K, Takahashi K, Sonoda T, Ishibashi M, Omoto R, Koyama F, Orita K, Takagi H.
    Int J Clin Pharmacol Res; 1991 Aug 23; 11(4):175-82. PubMed ID: 1813436
    [Abstract] [Full Text] [Related]

  • 9. Combined therapy of deoxyspergualin and plasmapheresis: a useful treatment for antibody-mediated acute rejection after kidney transplantation.
    Nojima M, Yoshimoto T, Nakao A, Maruyama T, Takiuchi H, Izumi M, Hashimoto M, Kyo M, Shima H.
    Transplant Proc; 2005 Mar 23; 37(2):930-3. PubMed ID: 15848578
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Association of treatment with 15-deoxyspergualin and BK virus nephropathy in kidney allograft recipients.
    Shi Y, Moriyama T, Namba Y, Yamanaka M, Hanafuse T, Imamura R, Ichimaru N, Oka K, Kyo M, Tian Y, Takahara S, Ichikawa S, Okuyama A.
    Clin Transplant; 2007 Mar 23; 21(4):502-9. PubMed ID: 17645710
    [Abstract] [Full Text] [Related]

  • 13. Effects of deoxyspergualin (DSG) administered in the chronic phase following kidney transplantation.
    Fudaba Y, Fukuda Y, Yamamoto H, Ohdan H, Shintaku S, Shibata S, Miyata Y, Marubayashi S, Asahara T, Dohi K.
    Transplant Proc; 1998 Nov 23; 30(7):3582-3. PubMed ID: 9838569
    [No Abstract] [Full Text] [Related]

  • 14. Therapeutic effect of 15-deoxyspergualin on acute graft rejection detected by 31P nuclear magnetic resonance spectrography, and its effect on rat heart transplantation.
    Suzuki S, Kanashiro M, Watanabe H, Amemiya H.
    Transplantation; 1988 Nov 23; 46(5):669-72. PubMed ID: 2973669
    [Abstract] [Full Text] [Related]

  • 15. [Rescue effect of 15-deoxyspergualin for acute rejection on heart transplantation--using a rat model].
    Bonkohara Y, Hachida M, Nonoyama M, Hoshi H, Imamaki M, Saito S, Koyanagi H.
    Nihon Kyobu Geka Gakkai Zasshi; 1994 Jan 23; 42(1):61-8. PubMed ID: 8308384
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics and pharmacodynamics of 15-deoxyspergualin in a canine renal allograft model of local immunosuppression.
    Gruber SA, Hughes SE, Xiao S, Perera S, Jayasankar V, Rosario AD, Singh J.
    J Surg Res; 1997 Aug 23; 71(2):137-44. PubMed ID: 9299281
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The immunopharmacology of immunosuppression by 15-deoxyspergualin.
    Yuh DD, Morris RE.
    Transplantation; 1993 Mar 23; 55(3):578-91. PubMed ID: 7681226
    [Abstract] [Full Text] [Related]

  • 19. Deoxyspergualin prophylaxis with tacrolimus further improves long-term graft survival in living-related renal-transplant recipients transfused with donor-specific blood.
    Amada N, Okazaki H, Sato T, Ohashi Y, Kikuchi H.
    Transplant Proc; 2005 Mar 23; 37(2):927-9. PubMed ID: 15848577
    [Abstract] [Full Text] [Related]

  • 20. Evidence that deoxyspergualin prevents sensitization and first-set cardiac xenograft rejection in rats by suppression of antibody formation.
    Valdivia LA, Monden M, Gotoh M, Nakano Y, Tono T, Mori T.
    Transplantation; 1990 Jul 23; 50(1):132-6. PubMed ID: 2368132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.